Gemcitabine/Nab-Paclitaxel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gemcitabine/Nab-Paclitaxel, covering 2021-07-01 to 2021-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer [NA]